{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fiambio.simplecast.com%2Fepisodes%2Fclinical-trials-and-tribulations-syza8CJV","width":444,"version":"1.0","type":"rich","title":"Clinical Trials and Tribulations","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/9b3967de-d938-42f2-b54e-99b29c007c9b/edf95499-0c7d-4519-8809-c86b3b8795c1/bio-podcast-logo-1.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/28ad6545-a4c4-4805-af2d-da3173e4fe26\" height=\"200\" width=\"100%\" title=\"Clinical Trials and Tribulations\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"As Moderna breaks the record for speed in starting the final stage of human testing for its covid vaccine, new BIO CEO Dr. Michelle McMurry-Heath tackles the thorny issue of how to best structure the historic Phase 3 clinical trial. The Boston biotech’s Chief Medical Officer reveals the strategy to test vaccine efficacy on communities of color and others hardest hit by the coronavirus.\n\nHosted by Dr. Michelle McMurry-Heath"}